PHASE I/II DOSE-ESCALATION TRIAL OF PATUPILONE EVERY 3 WEEKS IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY OVARIAN, PRIMARY FALLOPIAN, OR PRIMARY PERITONEAL CANCER
PHASE I/II DOSE-ESCALATION TRIAL OF PATUPILONE EVERY 3 WEEKS IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY OVARIAN, PRIMARY FALLOPIAN, OR PRIMARY PERITONEAL CANCER